Kruti Shah

Title: Kruti Shah: Innovator in T Lymphocyte Production Methods

Introduction

Kruti Shah is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of immunology, particularly in the production of T lymphocytes. His innovative methods have the potential to impact cancer treatment and viral infections.

Latest Patents

Kruti Shah holds a patent for "T lymphocyte production methods and T lymphocytes produced thereby." This patent outlines methods for generating T cells, specifically cytotoxic T lymphocytes, from peripheral blood mononuclear cells. Notably, his approach eliminates the need for a separate step to generate and isolate antigen-presenting cells, utilizing a single round of antigen stimulation. The methods described in his patent can be utilized for treating cancer and viral infections.

Career Highlights

Kruti Shah is currently employed at Celgene Corporation, where he continues to advance his research in immunotherapy. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.

Collaborations

Some of his coworkers include Wei Liu and Kathy E Karasciewicz-Mendez, who contribute to the collaborative environment at Celgene Corporation.

Conclusion

Kruti Shah's contributions to T lymphocyte production methods exemplify the intersection of innovation and healthcare. His work holds promise for improving treatment options for patients facing serious health conditions.